The Magazine for Sleep Professionals
Wednesday, October 14, 2026
As America prepares to observe Veterans Day in honor of those who served, fought, and died for us, AirAvant Medical and First Nation Group announce a partnership alliance providing the FDA-cleared Bongo® Rx Expiratory Positive Airway Pressure (EPAP) device to Veterans and active-duty military members suffering from Obstructive Sleep Apnea (OSA). The partnership between First Nation […]
Signifier Medical Technologies Ltd, has announced it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. Following FDA authorization and clearance for marketing in February 2021, eXciteOSA has been quickly adopted by physicians and patients alike. The first of its kind, eXciteOSA is a daytime treatment for snoring and mild obstructive […]
Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, today announced positive data across multiple endpoints from a Phase 2 randomized, double-blind, placebo-controlled, four-period, single-dose crossover factorial clinical trial (APC-003), and a 28-day open-label extension study, evaluating AD109 as […]
Sommetrics announced the launch of the pivotal clinical trial of its aerSleep® II device for the treatment of obstructive sleep apnea (OSA). This study is being conducted at 10 university and community-based sleep centers in the U.S. under an Investigational Device Exemption approved by the Food and Drug Administration. Termed the […]
Nyxoah SA has announced that the U.S. Food and Drug Administration has granted the Genio® bilateral hypoglossal nerve stimulation system Breakthrough Device Designation for the treatment of adult patients with moderate to severe OSA and Complete Concentric Collapse (CCC) of the soft palate. The FDA’s Breakthrough Designation Program was created […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides recommendations for the referral of adults with obstructive sleep apnea for surgical consultation. Surgical treatment of OSA can be an option for patients who struggle with CPAP therapy and others with certain anatomic features. The guideline, available online as […]
Mintal, an emerging wellness and lifestyle brand, has launched two flagship sleep apps, Mintal Sleep and Mintal Tracker, that address sleep disorders, anxiety and mental health concerns. Mintal focuses on improving people’s overall well-being through scientifically informed wellness techniques and innovations. This includes a new approach for detecting sleep apnea […]
There’s a new name in the study of untreated sleep apnea and the high-tech effort to identify and treat tens of millions of Americans afflicted by it: Primasun. Translating to “first light,” Primasun is the moniker for a joint venture formed in 2018 by Verily, a subsidiary of Alphabet focused […]
Apnimed raised $25 million in a Series B financing led by existing investor, Morningside Ventures, and joined by new investors, Seligman Investments and Tao Capital Partners. The proceeds will support Apnimed’s ongoing development and commercialization plans. The company is advancing its lead program, AD109, an oral disease-modifying therapeutic for the […]
Signifier Medical Technologies, an innovator in the sleep-disordered breathing market, announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has received the prestigious GOOD DESIGN® Award in the Medical category. The device was recently approved by the U.S. Food and Drug Administration […]
